Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) ...

The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.

The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.